A Novel Fluorescent Gemcitabine Prodrug That Follows a Nucleoside Transporter-Independent Internalization and Bears Enhanced Therapeutic Efficacy With Respect to Gemcitabine.
Vrettos EΙ, Kyrkou SG, Zoi V, Giannakopoulou M, Chatziathanasiadou MV, Kanaki Z, Agalou A, Bistas VP, Kougioumtzi A, Karampelas T, Diamantis DA, Murphy C, Beis D, Klinakis A, Tamvakopoulos C, Kyritsis AP, Alexiou GA, Tzakos AG.
Vrettos EΙ, et al. Among authors: murphy c.
Chemistry. 2024 Sep 5;30(50):e202401327. doi: 10.1002/chem.202401327. Epub 2024 Aug 19.
Chemistry. 2024.
PMID: 38941241